

IT services company Phoenix IT Group soared Monday morning after a strong performance by its business continuity division drove revenue and profits hi...


Shares in gene therapy company Oxford Biomedica surged after it presented updated analyses of its trials of its TroVax drug on colorectal and renal ca...


Gene therapy company Oxford Biomedica said all patients treated thus far in its Phase I/II trial of ProSavin, its Parkinson's disease treatment, have ...


Shares in Oxford BioMedica are up after the gene therapy group said the new ocular collaboration with sanofi-aventis and the termination of the TroVax...